TY  - JOUR
PY  - 2018//
TI  - Prevalence, diagnosis, and treatment rates of mood disorders among opioid users under criminal justice supervision
JO  - Substance use and misuse
A1  - Mbaba, Mary
A1  - Brown, Shan-Estelle
A1  - Wooditch, Alese
A1  - Kiss, Marissa
A1  - Murphy, Amy
A1  - Kumari, Suneeta
A1  - Taxman, Faye
A1  - Altice, Frederick
A1  - Lawson, William B.
A1  - Springer, Sandra A.
SP  - 1519
EP  - 1528
VL  - 53
IS  - 9
N2  - BACKGROUND: Individuals involved in the criminal justice system have disproportionately high rates of psychiatric disorders when compared to the general U.S. POPULATION: If left untreated, the likelihood of subsequent arrest increases and risk for adverse health consequences is great, particularly among opioid users. <br><br>OBJECTIVES: To explore the prevalence, characteristics, and treatment of mood disorders among justice involved opioid-dependent populations. <br><br>METHODS: The current study enrolled 258 treatment-seeking opioid-dependent individuals under community-based criminal justice supervision (e.g., probation, parole) screened from the larger parent study, Project STRIDE, a seek/test/treat randomized control trial (RCT) examining HIV and opioid use treatment. During baseline, individuals were screened for depression using the Patient Health Questionnaire-9 (PHQ-9) and screened for bipolar disorder using the Mood Disorder Questionnaire (MDQ) tool. <br><br>RESULTS: Overall, 78 (30%) participants screened positive for moderate to severe depression and 54 (21%) screened positive for bipolar disorder. Participants self-reported mood disorders at higher rates than they screened positive for these conditions. Participants screening positive for these conditions experienced significantly greater family, legal, and medical problems on the Addiction Severity Index-Lite (ASI-Lite) than those who did not screen positive. Incidence of a lifetime suicide attempt was found to be associated with a positive screen for both mood disorders. Prescribed psychotropic treatment utilization was similar among those who screened positive for depression or bipolar disorder with approximately 38% reporting taking medication. <br><br>IMPORTANCE: Findings suggest universal mood disorder screening to improve comprehensive psychiatric care and treatment of opioid-dependent justice-involved individuals.<p />  <p>Language: en</p>
LA  - en
SN  - 1082-6084
UR  - http://dx.doi.org/10.1080/10826084.2017.1416400
ID  - ref1
ER  -